These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


141 related items for PubMed ID: 11591569

  • 1. Ipratropium bromide hydrofluoroalkane inhalation aerosol is safe and effective in patients with COPD.
    Taylor J, Kotch A, Rice K, Ghafouri M, Kurland CL, Fagan NM, Witek TJ, Ipratropium Bromide HFA Study Group.
    Chest; 2001 Oct; 120(4):1253-61. PubMed ID: 11591569
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover study in patients with asthma.
    Maesen FP, Greefhorst LP, Smeets JJ, Wald FD, Cornelissen PJ.
    Respiration; 1997 Oct; 64(4):273-80. PubMed ID: 9257362
    [Abstract] [Full Text] [Related]

  • 5. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
    Fireman P, Prenner BM, Vincken W, Demedts M, Mol SJ, Cohen RM.
    Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
    [Abstract] [Full Text] [Related]

  • 6. Ipratropium bromide HFA.
    Wellington K.
    Treat Respir Med; 2005 May; 4(3):215-20; discussion 221-2. PubMed ID: 15987237
    [Abstract] [Full Text] [Related]

  • 7. Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma. Azmacort HFA Clinical Study Group.
    Jacobson K, Chervinsky P, Noonan M, Kane RE, Banerji D, Uryniak T.
    Ann Allergy Asthma Immunol; 1999 Oct; 83(4):327-33. PubMed ID: 10541425
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Safety of long-term treatment with HFA albuterol.
    Ramsdell JW, Klinger NM, Ekholm BP, Colice GL.
    Chest; 1999 Apr; 115(4):945-51. PubMed ID: 10208190
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol.
    Bronsky E, Ekholm BP, Klinger NM, Colice GL.
    J Asthma; 1999 Apr; 36(1):107-14. PubMed ID: 10077140
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with asthma.
    Lumry W, Noveck R, Weinstein S, Barnhart F, Vandermeer A, Murray A, Reisner C.
    Ann Allergy Asthma Immunol; 2001 Mar; 86(3):297-303. PubMed ID: 11289328
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of beclomethasone dipropionate extrafine aerosol in childhood asthma: a 12-week, randomized, double-blind, placebo-controlled study.
    Nayak A, Lanier R, Weinstein S, Stampone P, Welch M.
    Chest; 2002 Dec; 122(6):1956-65. PubMed ID: 12475833
    [Abstract] [Full Text] [Related]

  • 19. A controlled trial of chlorofluorocarbon-free triamcinolone acetonide inhalation aerosol in the treatment of adult patients with persistent asthma. Azmacort HFA Study Group.
    Welch M, Bernstein D, Gross G, Kane RE, Banerji D.
    Chest; 1999 Nov; 116(5):1304-12. PubMed ID: 10559092
    [Abstract] [Full Text] [Related]

  • 20. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
    Ayres JG, Millar AB, Sykes AP.
    Respir Med; 2000 Jun; 94 Suppl B():S42-50. PubMed ID: 10919685
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.